Profile data is unavailable for this security.
About the company
ANI Pharmaceuticals, Inc. is a diversified biopharmaceutical company, which serves patients in need by developing, manufacturing and marketing branded and generic prescription pharmaceutical products, including for diseases with high unmet medical need. The Company is focused on delivering sustainable growth by scaling up its Rare Disease business through its lead asset, Purified Cortrophin Gel, as well as its generics business with enhanced research and development capabilities. Its three pharmaceutical manufacturing facilities, of which two are located in Baudette, Minnesota, and one is located in East Windsor, New Jersey, are together capable of producing oral solid dose products, as well as semi-solids, liquids and topicals, controlled substances, and potent products. The Company has a commercial portfolio of approximately 118 products with a variety of indications and a robust portfolio of pipeline products.
- Revenue in USD (TTM)538.95m
- Net income in USD22.95m
- Incorporated2001
- Employees642.00
- LocationANI Pharmaceuticals Inc210 Main Street WestBAUDETTE 56623United StatesUSA
- Phone+1 (218) 634-3500
- Fax+1 (218) 634-3540
- Websitehttps://www.anipharmaceuticals.com/
Mergers & acquisitions
Acquired company | ANIP:NMQ since announced | Transaction value |
---|---|---|
Alimera Sciences Inc | 4.97% | 314.33m |